Blog written by Dr. Matias Fernandez Vina. Ceo of Stem Cell Therapy Argentina.
Dosing in medical treatments is not ignored in any other area of medicine because dosage is often critical to the success of the treatment. However, in orthobiologic and regenerative therapies, 99% of the clinics you might go to have no idea of the dosage of PRP or Mesenchymal Stem Cells they are injecting. You can corroborate this in a regenerative medical practice, you can ask how many platelets or stem cells they put in you… and they just tell you how many tubes or volume of tissue they get you… but it is difficult to know the final dose of the product to put in.
In recent years, advanced orthobiological practices have begun to pay attention to PRP dosing. We have been promoting it for more than 7 years.
Stem Cell Therapy Argentina is part of the 1% of clinics that provide biological products for regenerative medicine, both platelet-rich plasma and mesenchymal stem cells from bone marrow and adipose tissue.
Stem Cell Therapy Argentina quantifies doses higher than 6 billion platelets for Platelet Rich Plasma. We call this PRP“Hyperconcentrated PRP“, and although many clinics replicate this name, it is registered by the regulatory body in Argentina [INPI], under our trademark, being a 100% original protocol of multiple injections.
The same happens with cell therapy and expanded mesenchymal stem cells from adipose tissue. Stem Cell Therapy Argentina offers injections of 100 million mesenchymal cells for the control of degenerative osteoarthritis of the knee, hip and shoulder, and 20 million for tendons and ligaments.
Undoubtedly, the success of the treatments we have with patients depends on what 1% of the clinics, such as Stem Cell Therapy Argentina, perform, protocols strictly elaborated by personnel who are 100% dedicated to regenerative medicine and advanced therapies.
